CN106491815A - A kind of Chinese medicine for treating prolapse of lumbar intervertebral disc - Google Patents

A kind of Chinese medicine for treating prolapse of lumbar intervertebral disc Download PDF

Info

Publication number
CN106491815A
CN106491815A CN201611071518.XA CN201611071518A CN106491815A CN 106491815 A CN106491815 A CN 106491815A CN 201611071518 A CN201611071518 A CN 201611071518A CN 106491815 A CN106491815 A CN 106491815A
Authority
CN
China
Prior art keywords
radix
intervertebral disc
lumbar intervertebral
herba
prolapse
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611071518.XA
Other languages
Chinese (zh)
Inventor
佘延英
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201611071518.XA priority Critical patent/CN106491815A/en
Publication of CN106491815A publication Critical patent/CN106491815A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/17—Gnetophyta, e.g. Ephedraceae (Mormon-tea family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232—Angelica
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238—Saposhnikovia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
    • A61K36/268—Asarum (wild ginger)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
    • A61K36/296—Epimedium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/487—Psoralea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/804—Rehmannia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a kind of Chinese medicine for treating prolapse of lumbar intervertebral disc, and it is made up of the raw material of following weight proportioning：Radix Astragali 120～250, Radix Angelicae Sinensis 30～80, Radix Rehmanniae Preparata 30～80, teata glycinises 30～80, Herba Ephedrae 15～40, Herba Asari 18～40, Ramulus Cinnamomi 45～100, the Radix Paeoniae Alba 45～100, Radix Saposhnikoviae 30～80, Semen Cuscutae 30～80, Fructus Psoraleae 30～80, Herba Epimedii 30～80.The Chinese medicine of present invention treatment prolapse of lumbar intervertebral disc is with Radix Astragali as principal agent, arrange in pairs or groups other accessory drugss, they influence each other, synergism, so as to play good bone and muscle strengthening, blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, analgesic effect of curing the wound, have a good curative effect to prolapse of lumbar intervertebral disc, and its raw material is simple, taking convenience.

Description

A kind of Chinese medicine for treating prolapse of lumbar intervertebral disc
Technical field
The present invention relates to technical field of Chinese medicines, and in particular to a kind of Chinese medicine for treating prolapse of lumbar intervertebral disc.
Background technology
Prolapse of lumbar intervertebral disc is one of relatively conventional illness, is primarily due to lumbar intervertebral disc each several part (vertebral pulp, fiber Ring and cartilaginous lamina), especially vertebral pulp, after having different degrees of degenerative change, in the presence of external force factor, the fibre of intervertebral disc Dimension ring breakage, nucleus pulposus cause adjacent spinal nerve root to be pierced from rupture part prominent (or abjection) in rear or intraspinal tube Swash or oppress, so as to produce flank pain, a series of clinical symptoms such as side lower limb or double lower limb numbness, pain.Lumbar intervertebral disc Herniation accounts for 95% with waist 4～5,1 sickness rate highest of waist 5- sacrums.The medicine for the treatment of prolapse of lumbar intervertebral disc is numerous at present, for example Publication No.：CN106109691A, entitled《A kind of pharmaceutical composition for treating prolapse of lumbar intervertebral disc》Chinese invention patent Application, the present invention relates to pharmaceutical compounding techniques field, specially a kind of pharmaceutical composition for treating prolapse of lumbar intervertebral disc, including in Medical herbs major ingredient and food adjuvant, the Chinese herbal medicine major ingredient include animal drugs 30-40g, mineral drug 6-14g and plant amedica, wherein plant Thing medicine includes following composition by weight：Radix Astragali 15g, Radix Salviae Miltiorrhizae 20g, Poria 20g, Radix Paeoniae Alba 10g, Radix Glycyrrhizae 6g, Flos Carthami 5g, Rhizoma Corydalis 10g, river Rhizome of chuanxiong 6g, Radix Rehmanniae 15g, Radix Angelicae Sinensis 20g, Herba Taxilli 20g, Maackia amurensis Rupr et Maxim plum 20g, Heiguteng exract 20g, Radix Clematidis 20g, the food adjuvant include Following composition by weight：Fructus Chaenomeliss 10g, sweet potato extract 8g, cauliflower extract 14g.The present invention have treatment rheumatoid arthritiss, Invigorating kidney, promoting blood circulation, tune liver yin nourishing, the effect of bone and muscle strengthening.But its compatibility is complex.
Content of the invention
The technical problem to be solved in the present invention is to provide that a kind of compatibility is relatively simple, safe and reliable, eutherapeutic treatment waist The Chinese medicine of intervertebral disk hernia.
For solving above-mentioned technical problem, the present invention is employed the following technical solutions：
The Chinese medicine of present invention treatment prolapse of lumbar intervertebral disc, is made up of the raw material of following weight proportioning：
Radix Astragali 120～250, Radix Angelicae Sinensis 30～80, Radix Rehmanniae Preparata 30～80, teata glycinises 30～80, Herba Ephedrae 15～40, Herba Asari 18～ 40th, Ramulus Cinnamomi 45～100, the Radix Paeoniae Alba 45～100, Radix Saposhnikoviae 30～80, Semen Cuscutae 30～80, Fructus Psoraleae 30～80, Herba Epimedii 30～80.
The preferred weight proportioning of each raw material is：
Radix Astragali 150～220, Radix Angelicae Sinensis 40～60, Radix Rehmanniae Preparata 40～60, teata glycinises 40～60, Herba Ephedrae 20～30, Herba Asari 25～ 35th, Ramulus Cinnamomi 60～80, the Radix Paeoniae Alba 60～80, Radix Saposhnikoviae 40～60, Semen Cuscutae 40～60, Fructus Psoraleae 40～60, Herba Epimedii 40～60.
The best weight ratio of each raw material is：
Radix Astragali 200, Radix Angelicae Sinensis 50, Radix Rehmanniae Preparata 50, teata glycinises 50, Herba Ephedrae 25, Herba Asari 30, Ramulus Cinnamomi 70, the Radix Paeoniae Alba 70, Radix Saposhnikoviae 50, Tu SIZI 50, Fructus Psoraleae 50, Herba Epimedii 50.
The present invention treats the preparation method of the Chinese medicine of prolapse of lumbar intervertebral disc：Weigh by weight ratio raw material Radix Astragali, Radix Angelicae Sinensis, Radix Rehmanniae Preparata, teata glycinises, Herba Ephedrae, Herba Asari, Ramulus Cinnamomi, the Radix Paeoniae Alba, Radix Saposhnikoviae, Semen Cuscutae, Fructus Psoraleae, Herba Epimedii, add 5～8 times of raw material weights Decocting boil, water boiling after be cooked by slow fire 30～40 minutes, leach medicinal liquid, obtain final product.
The present invention treats the instructions of taking of the Chinese medicine of prolapse of lumbar intervertebral disc：Orally, 2 times a day, each serving 200～250 Gram.
The present invention treats the Chinese medicine of prolapse of lumbar intervertebral disc with Radix Astragali as principal agent, other accessory drugss of arranging in pairs or groups, and they influence each other, association Same-action, so as to play good bone and muscle strengthening, blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema, analgesic effect of curing the wound have very to prolapse of lumbar intervertebral disc Good curative effect, and its raw material is simple, taking convenience.
Specific embodiment
With embodiment, the invention will be further described below, but the invention is not limited in these embodiments.
Number described in following embodiment is weight portion.
Embodiment 1
Drug weight proportioning：
120 parts of Radix Astragali, 30 parts of Radix Angelicae Sinensis, 30 parts of Radix Rehmanniae Preparata, 30 parts of teata glycinises, 15 parts of Herba Ephedrae, 18 parts of Herba Asari, 45 parts of Ramulus Cinnamomi, white 45 parts of Chinese herbaceous peony, 30 parts of Radix Saposhnikoviae, 30 parts of Semen Cuscutae, 30 parts of Fructus Psoraleae, 30 parts of Herba Epimedii.
Preparation method：
Raw material is weighed by above-mentioned weight proportion, adds the decocting of 5 times of raw material weights to boil, be cooked by slow fire 30 minutes after water boiling, filter Go out medicinal liquid, obtain final product.
Embodiment 2
Drug weight proportioning：
250 parts of Radix Astragali, 80 parts of Radix Angelicae Sinensis, 80 parts of Radix Rehmanniae Preparata, 80 parts of teata glycinises, 40 parts of Herba Ephedrae, 40 parts of Herba Asari, 100 parts of Ramulus Cinnamomi, white 100 parts of Chinese herbaceous peony, 80 parts of Radix Saposhnikoviae, 80 parts of Semen Cuscutae, 80 parts of Fructus Psoraleae, 80 parts of Herba Epimedii.
Preparation method：
Raw material is weighed by above-mentioned weight proportion, adds the decocting of 8 times of raw material weights to boil, be cooked by slow fire 40 minutes after water boiling, filter Go out medicinal liquid, obtain final product.
Embodiment 3
Drug weight proportioning：
200 parts of Radix Astragali, 50 parts of Radix Angelicae Sinensis, 50 parts of Radix Rehmanniae Preparata, 50 parts of teata glycinises, 25 parts of Herba Ephedrae, 30 parts of Herba Asari, 70 parts of Ramulus Cinnamomi, white 70 parts of Chinese herbaceous peony, 50 parts of Radix Saposhnikoviae, 50 parts of Semen Cuscutae, 50 parts of Fructus Psoraleae, 50 parts of Herba Epimedii.
Preparation method：
Raw material is weighed by above-mentioned weight proportion, adds the decocting of 6 times of raw material weights to boil, be cooked by slow fire 35 minutes after water boiling, filter Go out medicinal liquid, obtain final product.
Experimental example：
The beneficial effect of the Chinese medicine of present invention treatment prolapse of lumbar intervertebral disc is expanded on further below by way of experimental example.
1st, Subject Population：
It is divided into two experimental grouies of A, B：
A groups：Female patient 100；35～50 years old age.
B groups：Male patient 150；35～55 years old age.
2nd, drug administration method：
The Chinese medicine of 3 obtained treatment prolapse of lumbar intervertebral disc of the oral embodiment of the present invention is daily 2 times, each serving 250 grams, serve on 20 days.
3rd, efficacy evaluation：
(1) invalid：Compared with before medication, therapeutic effect is not obvious.
(2) effective：Therapeutic effect is obvious.
4th, therapeutic effect：

Claims (3)

1. a kind of Chinese medicine for treating prolapse of lumbar intervertebral disc, it is characterised in that be made up of the raw material of following weight proportioning：
Radix Astragali 120～250, Radix Angelicae Sinensis 30～80, Radix Rehmanniae Preparata 30～80, teata glycinises 30～80, Herba Ephedrae 15～40, Herba Asari 18～40, osmanthus Branch 45～100, Radix Paeoniae Alba 45～100, Radix Saposhnikoviae 30～80, Semen Cuscutae 30～80, Fructus Psoraleae 30～80, Herba Epimedii 30～80.
2. the Chinese medicine for the treatment of prolapse of lumbar intervertebral disc according to claim 1, it is characterised in that the weight proportion of each raw material is：
Radix Astragali 150～220, Radix Angelicae Sinensis 40～60, Radix Rehmanniae Preparata 40～60, teata glycinises 40～60, Herba Ephedrae 20～30, Herba Asari 25～35, osmanthus Branch 60～80, Radix Paeoniae Alba 60～80, Radix Saposhnikoviae 40～60, Semen Cuscutae 40～60, Fructus Psoraleae 40～60, Herba Epimedii 40～60.
3. the Chinese medicine for the treatment of prolapse of lumbar intervertebral disc according to claim 2, it is characterised in that the weight proportion of each raw material is：
Radix Astragali 200, Radix Angelicae Sinensis 50, Radix Rehmanniae Preparata 50, teata glycinises 50, Herba Ephedrae 25, Herba Asari 30, Ramulus Cinnamomi 70, the Radix Paeoniae Alba 70, Radix Saposhnikoviae 50, Semen Cuscutae 50th, Fructus Psoraleae 50, Herba Epimedii 50.
CN201611071518.XA 2016-11-29 2016-11-29 A kind of Chinese medicine for treating prolapse of lumbar intervertebral disc Pending CN106491815A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611071518.XA CN106491815A (en) 2016-11-29 2016-11-29 A kind of Chinese medicine for treating prolapse of lumbar intervertebral disc

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611071518.XA CN106491815A (en) 2016-11-29 2016-11-29 A kind of Chinese medicine for treating prolapse of lumbar intervertebral disc

Publications (1)

Publication Number Publication Date
CN106491815A true CN106491815A (en) 2017-03-15

Family

ID=58328859

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611071518.XA Pending CN106491815A (en) 2016-11-29 2016-11-29 A kind of Chinese medicine for treating prolapse of lumbar intervertebral disc

Country Status (1)

Country Link
CN (1) CN106491815A (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102038930A (en) * 2010-09-19 2011-05-04 左霖 Medicament for treating protrusion of lumbar vertebral disc
CN102258754A (en) * 2010-05-27 2011-11-30 杨晓杰 Medicine for treating protrusion of lumbar vertebral disc
CN104069468A (en) * 2014-07-16 2014-10-01 张湛 Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102258754A (en) * 2010-05-27 2011-11-30 杨晓杰 Medicine for treating protrusion of lumbar vertebral disc
CN102038930A (en) * 2010-09-19 2011-05-04 左霖 Medicament for treating protrusion of lumbar vertebral disc
CN104069468A (en) * 2014-07-16 2014-10-01 张湛 Traditional Chinese medicine composition for treating lumbar intervertebral disc protrusion

Similar Documents

Publication Publication Date Title
CN102772745B (en) Chinese medicinal preparation for treating cancer and preparation method thereof
CN103393879B (en) Traditional Chinese medicine composition for treating liver and kidney deficiency
CN103550532B (en) Traditional Chinese medicine (TCM) composition for treating palpitation
CN101972386A (en) Traditional Chinese medicine for treating diabetic gout
CN102363022B (en) Chinese medicine for treating postpartum anemic fainting
CN101897879B (en) Traditional Chinese medicine for treating rheumatic arthritis
CN101112537A (en) Chinese traditional medicine preparations for treating hyperosteogeny disease
CN101850071B (en) Chinese medicament for treating chronic nephritis
CN103800840A (en) Oral traditional Chinese medicine solution for treating cervical spondylosis
CN103721082A (en) Traditional Chinese medicinal composition for treating scapulohumeral periarthritis
CN102327410B (en) Traditional Chinese medicine composition for treating epigastric fullness
CN101961448A (en) Chinese medicament for treating diabetic gout
CN106491815A (en) A kind of Chinese medicine for treating prolapse of lumbar intervertebral disc
CN104623330A (en) Chinese medicinal composition for treating hyperlipidemia
CN101530593B (en) Traditional Chinese medicine for treating diabetic numbness of extremities
CN102091265A (en) Traditional Chinese medicine for treating diabetic gout
CN101530479B (en) Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy
CN102114225A (en) Traditional Chinese medicine for treating gout of diabetes patient
CN106361841A (en) Traditional Chinese medicine for treating ankylosing spondylitis
CN101554445B (en) Traditional Chinese medicine for treating diabetic hyperlipemia
CN101966279A (en) Traditional Chinese medicine for treating diabetic gout
CN104758888A (en) Traditional Chinese medicine composition for treating diabetes
CN104352756A (en) Traditional Chinese medicine composition for treating hyperosteogeny
CN101966280A (en) Traditional Chinese medicine for treating diabetes mellitus and gout
CN101843756B (en) Chinese medicament for treating chronic nephritis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20170315

WD01 Invention patent application deemed withdrawn after publication